Key Events This Week
23 Mar: Stock declines 1.41% amid broad market sell-off
24 Mar: Hits upper circuit at Rs.30.29, surging 4.16%
25 Mar: Recovers modestly, closing flat at Rs.29.36 (+1.14%)
27 Mar: Plunges to lower circuit, closing at Rs.28.41 (-3.24%)

Below All Moving Averages and Now at Lower Circuit: Mangalam Drugs and Organics Ltd Loses 3.9% in a Single Session
2026-03-27 13:00:04At Rs 28.43, sellers were still queuing — but there were no buyers willing to take the other side. Mangalam Drugs and Organics Ltd locked at its lower circuit of 5% on 27 Mar 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity.
Read full news article
Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 4.16% Gain — Buyers Queue, Sellers Absent
2026-03-24 10:00:07At Rs 30.53, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 4.16% on 24 Mar 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure
2026-03-19 13:00:05Shares of Mangalam Drugs and Organics Ltd plunged sharply on 19 Mar 2026, hitting the lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical micro-cap witnessed a maximum daily loss of 4.77%, closing at ₹29.16, reflecting a significant investor sell-off amid deteriorating market sentiment and weak technical indicators.
Read full news article
Mangalam Drugs and Organics Ltd is Rated Strong Sell
2026-03-19 10:10:20Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 19 March 2026, providing investors with the latest insights into its performance and outlook.
Read full news article








